Alteration of serum thymus and activation‐regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti‐interleukin‐17A agents

The Journal of Dermatology, EarlyView.


https://ift.tt/2H4qZch